Archer-Daniels-Midland Co ADM

Consumer staples SIC 2070 - Fats & Oils NAICS Manufacturing › Food Manufacturing derived NYSE

Archer-Daniels-Midland Company and its subsidiaries (the "Company" or "ADM") unlocks the power of nature to enrich the quality of life. The Company is an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. ADM is also a premier human and animal nutrition provider, as well as a leader in health and well-being products.

The Company partners with thousands of farmers around the world to purchase their crops and uses its integrated global origination, logistics, and manufacturing network to transform many of those raw commodities into an expansive array of products serving the food, feed, fuel, and industrial and consumer products sectors. The Company offers a broad portfolio of food and beverage products, from staple foods to innovative alternatives, such as natural colors and flavors, plant-based proteins, and lower-sugar, fat, and salt solutions. ADM provides human and animal nutrition ingredients and solutions that support health, productivity, and sustainability. It offers a wide range of health and well-being products, such as probiotics, enzymes, and supplements to meet the needs of consumers looking for new ways to live healthier lives. ADM is a key producer of biofuels, converting agricultural feedstocks into renewable fuels used in transportation and industrial applications. ADM is a cutting-edge innovator, investing in research, application development, and process improvement to deliver value-added products, enhance supply chain efficiency, and advance sustainable agricultural and nutrition solutions. It continues to develop a broad range of new bio-based consumer and industrial solutions as well as advance and scale its carbon capture and sequestration capabilities and other initiatives. ADM is a leader in business-driven sustainability efforts that support a strong agricultural sector, resilient supply chains, and a vast and growing bioeconomy. Around the globe, ADM's expertise and innovation are meeting critical needs from harvest to home.

Last close 80.14 2026-10-23
Market cap $38.62B 2026-06-30 share count
52-week range 55.58 - 88.75

Valuation FY2025 figures against the last close

P/S1.5x
P/E35.9x
P/FCF9.2x
EV/EBITDA—
Dividend yield2.6%
Diluted EPS2.23

Where the revenue comes from as reported in the latest 10-K

Revenue by segment

  • Carbohydrate Solutions
  • Ag Services and Oilseeds
  • Nutrition
Revenue by segment, 3 categories over 3 years. The same figures are in the table below. FY2025 Carbohydrate Solutions, FY2025: 8.5B (34.7%) 35% Carbohydrate Solutions Ag Services and Oilseeds, FY2025: 8.5B (34.7%) 35% Ag Services and Oilseeds Nutrition, FY2025: 7.5B (30.7%) 31% Nutrition FY2024 Carbohydrate Solutions, FY2024: 9B (37.5%) 38% Ag Services and Oilseeds, FY2024: 7.6B (31.8%) 32% Nutrition, FY2024: 7.3B (30.7%) 31% FY2023 Carbohydrate Solutions, FY2023: 10.4B (41.2%) 41% Ag Services and Oilseeds, FY2023: 7.6B (30.2%) 30% Nutrition, FY2023: 7.2B (28.5%) 29%
Segment FY2025FY2024FY2023
Carbohydrate Solutions $8.50B $8.98B $10.42B
Ag Services and Oilseeds $8.49B $7.61B $7.64B
Nutrition $7.51B $7.35B $7.21B

As the company reported it, from the “Revenues - Disaggregation of Revenues (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $24.96B$24.37B$25.69B$27.61B$85.25B$64.36B$64.66B$64.34B$60.83B$62.35B
Cost of revenue $75.24B$79.75B$86.42B$93.99B$79.26B$59.90B$60.51B$60.16B$57.31B$58.73B
Gross profit $5.03B$5.78B$7.51B$7.57B$5.99B$4.45B$4.15B$4.18B$3.52B$3.62B
R&D $246.0M$269.0M$256.0M$216.0M$171.0M$160.0M$154.0M$141.0M$129.0M$123.0M
SG&A $3.61B$3.71B$3.46B$3.36B$2.99B$2.69B$2.49B$2.17B$1.98B$1.98B
Interest expense $612.0M$706.0M$647.0M$396.0M$265.0M$339.0M$402.0M$364.0M$330.0M$293.0M
Pre-tax income $1.25B$2.25B$4.29B$5.23B$3.31B$1.88B$1.59B$2.06B$1.61B$1.82B
Income tax $182.0M$476.0M$828.0M$868.0M$578.0M$101.0M$209.0M$245.0M$7.0M$534.0M
Net income $1.08B$1.80B$3.48B$4.34B$2.71B$1.77B$1.38B$1.81B$1.59B$1.28B
EPS, basic 2.233.666.447.724.803.162.453.212.802.18
EPS, diluted 2.233.656.437.714.793.152.443.192.792.16
Shares, diluted (wtd. avg.) 484.0M493.0M542.0M563.0M566.0M565.0M565.0M567.0M572.0M591.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $1.01B$611.0M$1.37B$7.03B$7.45B$4.65B$2.99B$3.84B$1.86B$1.56B
Short-term investments ———————$6.0M$0—
Receivables $3.02B$3.71B$4.23B$4.93B$3.31B$2.79B$2.27B$2.23B$1.95B$1.91B
Inventory $10.37B$11.57B$11.96B$14.77B$14.48B$11.71B$9.17B$8.81B$9.17B$8.83B
Total current assets $26.66B$27.72B$29.77B$35.41B$31.91B$27.29B$21.35B$20.59B$19.93B$21.05B
Property, plant and equipment $11.18B$10.84B$10.51B$9.93B$9.80B$9.78B$10.11B$9.95B$10.14B$9.76B
Goodwill $4.77B$4.51B$4.10B$4.16B$4.18B$3.45B$3.38B$2.50B$2.37B$2.25B
Other intangibles $1.98B$2.26B$2.24B$2.38B$2.56B$2.13B$2.09B$1.54B$1.54B$1.46B
Total assets $52.39B$53.27B$54.63B$59.77B$56.14B$49.72B$44.00B$40.83B$39.96B$39.77B
Accounts payable $5.20B$5.54B$6.31B$7.80B$6.39B$4.47B$3.75B$3.54B$3.89B$3.61B
Short-term debt $1.01B$674.0M$1.0M$942.0M$570.0M$2.0M$7.0M$582.0M$13.0M$273.0M
Total current liabilities $19.53B$19.94B$18.66B$24.19B$21.95B$18.18B$13.73B$11.78B$12.57B$13.17B
Long-term debt $6.61B$7.58B$8.26B$7.74B$8.01B$7.88B$7.67B$7.70B$6.62B$6.50B
Retained earnings $21.98B$21.93B$23.46B$23.65B$21.66B$19.78B$18.96B$18.53B$17.55B$17.44B
Total equity $22.74B$22.18B$24.14B$24.32B$22.51B$20.02B$19.23B$19.00B$18.32B$17.18B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $5.45B$2.79B$4.46B$3.48B$6.59B-$2.39B-$5.45B-$4.78B-$5.97B-$6.51B
Depreciation and amortisation $1.18B$1.14B$1.06B$1.03B$996.0M$976.0M$993.0M$941.0M$924.0M$900.0M
Stock-based compensation $83.0M$74.0M$112.0M$147.0M$161.0M$151.0M$89.0M$109.0M$66.0M$74.0M
Capital expenditure $1.25B$1.56B$1.49B$1.32B$1.17B$823.0M$828.0M$842.0M$1.05B$882.0M
Investing cash flow -$1.02B-$2.70B-$1.50B-$1.40B-$2.67B$4.46B$5.26B$6.58B$7.29B$6.85B
Financing cash flow -$2.89B-$1.53B-$4.60B-$2.50B-$1.12B-$423.0M-$660.0M$187.0M-$1.03B-$579.0M
Dividends paid $987.0M$985.0M$977.0M$899.0M$834.0M$809.0M$789.0M$758.0M$730.0M$701.0M
Buybacks $0$2.33B$2.67B$1.45B$0$133.0M$150.0M$77.0M$750.0M$1.00B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000007084-26-000011.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 25B 50B 75B 100B Revenue, FY2016: 62.3B Gross profit, FY2016: 3.6B Net income, FY2016: 1.3B Revenue, FY2017: 60.8B Gross profit, FY2017: 3.5B Net income, FY2017: 1.6B Revenue, FY2018: 64.3B Gross profit, FY2018: 4.2B Net income, FY2018: 1.8B Revenue, FY2019: 64.7B Gross profit, FY2019: 4.1B Net income, FY2019: 1.4B Revenue, FY2020: 64.4B Gross profit, FY2020: 4.5B Net income, FY2020: 1.8B Revenue, FY2021: 85.2B Gross profit, FY2021: 6B Net income, FY2021: 2.7B Revenue, FY2022: 27.6B Gross profit, FY2022: 7.6B Net income, FY2022: 4.3B Revenue, FY2023: 25.7B Gross profit, FY2023: 7.5B Net income, FY2023: 3.5B Revenue, FY2024: 24.4B Gross profit, FY2024: 5.8B Net income, FY2024: 1.8B Revenue, FY2025: 25B Gross profit, FY2025: 5B Net income, FY2025: 1.1B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $62.35B $60.83B $64.34B $64.66B $64.36B $85.25B $27.61B $25.69B $24.37B $24.96B
Gross profit $3.62B $3.52B $4.18B $4.15B $4.45B $5.99B $7.57B $7.51B $5.78B $5.03B
Net income $1.28B $1.59B $1.81B $1.38B $1.77B $2.71B $4.34B $3.48B $1.80B $1.08B

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2070

TickerCompanyMarket capP/ERevenue growth
BG Bunge Global SA $20.03B 21.0x 9.0%
DAR DARLING INGREDIENTS INC. $8.87B 144.2x 7.4%
COOT Australian Oilseeds Holdings Ltd $10.6M — —